Ben Peacock, PhD

Bio:

Ben Peacock, PhD, Commercial Director at Sparta Biodiscovery, has specialised in nanoparticle characterisation for over a decade, with experience spanning EVs, lipid and polymer nanomedicines, and cell and gene therapy vectors. Ben now introduces industry and academia to SPARTA®, a single-particle Raman spectroscopy platform that resolves compositional heterogeneity at the individual particle level, characterising lipid ratios, surface targeting ligand density, and sub-populations otherwise invisible to bulk analysis. At PODD Ben will present how these particle-level insights translate into more informed formulation decisions and Quality-by-Design strategies for complex nanomedicines.